ConductScience.org, home

Paper12909451

Langerhans-cell histiocytosis: neoplasia or unbridled inflammation?

Fadeel B and 1 other. Trends Immunol, 2003. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Langerhans-cell histiocytosis: neoplasia or unbridled inflammation? Papers, record 12909451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12909451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Langerhans-cell histiocytosis: neoplasia or unbridled inflammation?
PubMed
Journal
Trends Immunol
PubMed
Year
2003
PubMed
Publication types
Comment, Letter
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.5
iCite
Revised in PubMed
2019-11-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fadeel BBengt
2Henter JIJan-Inge

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Histiocytosis, Langerhans-CellMajor topic
InflammationMajor topic
NeoplasmsMajor topic
Anti-Inflammatory Agents, Non-Steroidal
Child
Etanercept
Humans
Immunoglobulin G
Langerhans Cells
Phenotype
Receptors, Tumor Necrosis Factor

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on12697451Langerhans-cell histiocytosis 'insight into DC biology'.https://conductscience.org/library/papers/12697451

Source PubMed

Download CSV of comments and corrections

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
34146441Langerhans cell histiocytosis: A malignant myeloid neoplasm or disorder of immune regulation?Acta Paediatr2021https://conductscience.org/library/papers/34146441PubMed
27785447Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.Immunotargets Ther2016https://conductscience.org/library/papers/27785447PubMed
21654633Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.Mol Ther2011https://conductscience.org/library/papers/21654633PubMed
21351807Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.Paediatr Drugs2011https://conductscience.org/library/papers/21351807PubMed
20220088Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.J Immunol2010https://conductscience.org/library/papers/20220088PubMed
19424201Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions.Nat Med2009https://conductscience.org/library/papers/19424201PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12909451

GET https://conductscience.org/api/papers/v1/12909451/authors